Shopping Cart
- Remove All
Your shopping cart is currently empty
HS56 is an ATP-competitive dual Pim/DAPK3 inhibitor, displaying K_i values of 0.26 μM for DAPK3, 0.208 μM for Pim-3, 2.94 μM for Pim-1, and >100 μM for Pim-2. This compound effectively inhibits LC20 phosphorylation and smooth muscle contraction, and reduces blood pressure in spontaneously hypertensive mice, making it a valuable tool for hypertension research [HS-56].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks |
| Description | HS56 is an ATP-competitive dual Pim/DAPK3 inhibitor, displaying K_i values of 0.26 μM for DAPK3, 0.208 μM for Pim-3, 2.94 μM for Pim-1, and >100 μM for Pim-2. This compound effectively inhibits LC20 phosphorylation and smooth muscle contraction, and reduces blood pressure in spontaneously hypertensive mice, making it a valuable tool for hypertension research [HS-56]. |
| Targets&IC50 | PIM3:0.208 μM (Ki), PIM2:>100 μM (Ki), PIM1:2.94 μM (Ki) |
| In vitro | DMP-543 (XR-543) is a KV7 channel blocker, also acts as a potent neurotransmitter release enhancer.[1][2] DMP-543 enhances [3H]ACh release in rat brain slices (EC50: 700 nM).[2] |
| Molecular Weight | 317.75 |
| Formula | C13H8ClN5OS |
| Cas No. | 922050-57-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.